ArticleNature communications2021

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.

Julia Koerner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.